|
|
| | PF-CBP-1.HCl Basic information |
| Product Name: | PF-CBP-1.HCl | | Synonyms: | PF-CBP-1.HCl;PF 06670910;PF CBP1;PF 06670910;PFCBP1;PF06670910;PF06670910;PF-CBP1(PF-06670910) hydrochloride;5-(Dimethyl-1,2-oxazol-4-yl)-1-[2-(morpholin-4-yl)ethyl]-2-[2-(4-propoxyphenyl)ethyl]-1H-1,3-benzodiazole;1H-Benzimidazole, 5-(3,5-dimethyl-4-isoxazolyl)-1-[2-(4-morpholinyl)ethyl]-2-[2-(4-propoxyphenyl)ethyl]-;PFCBP1,PF-CBP-1,Inhibitor,Epigenetic Reader Domain,PF CBP1,PF-CBP1,inhibit | | CAS: | 1962928-21-7 | | MF: | C29H36N4O3 | | MW: | 488.62 | | EINECS: | | | Product Categories: | | | Mol File: | 1962928-21-7.mol |  |
| | PF-CBP-1.HCl Chemical Properties |
| Boiling point | 673.5±55.0 °C(Predicted) | | density | 1.20±0.1 g/cm3(Predicted) | | solubility | DMF: 30 mg/ml; DMF:PBS(pH 7.2)(1:1): 0.5 mg/ml; DMSO: 20 mg/ml; Ethanol: 20 mg/ml | | form | A crystalline solid | | pka | 6.90±0.10(Predicted) |
| | PF-CBP-1.HCl Usage And Synthesis |
| Uses | ISOX INACT was used to discover and prepare potent and selective in vivo probe (GNE-272) for bromodomains of CBP/EP300. |
| | PF-CBP-1.HCl Preparation Products And Raw materials |
|